These findings suggest that GIGYF2 may contribute to cognitive disorder development possibly by negatively modulating the level of phosphorylated IGF1R and its downstream signaling pathways, and hippocampus-specific down-regulation of GIGYF2 is beneficial for neuroprotection in diabetic encephalopathy. Here, IGF1R is linked to diabetic encephalopathy.